Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC

As shortened telomeres inhibit tumor formation and prolong life span in a Kras(G12D) mouse lung cancer model, we investigated the implications of telomerase in Kras-mutant NSCLC. We found that Kras mutations increased TERT (telomerase reverse transcriptase) mRNA expression and telomerase activity an...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Liu, Weiran, Yin, Yuesong, Wang, Jun, Shi, Bowen, Zhang, Lianmin, Qian, Dong, Li, Chenguang, Zhang, Hua, Wang, Shengguang, Zhu, Jinfang, Gao, Liuwei, Zhang, Qiang, Jia, Bin, Hao, Ligang, Wang, Changli, Zhang, Bin
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2016
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352098/
https://ncbi.nlm.nih.gov/pubmed/27329725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10162
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg